5 fluorouracil - direct healthcare professional communication (DHPC)

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct healthcare professional communication (DHPC): Medicines containing 5-fluorouracil (i.v.): In patients with moderate or severe renal impairment, DPD deficiency by measuring blood uracil levels should be interpreted with caution

Key facts

• Active substance:
  5 fluorouracil
• Therapeutic area (MeSH):
  Neoplasms
• Procedure number:
  PSUSA/00000007/202312
• DHPC type:
  Periodic safety update single assessment
• Dissemination date:
  24/10/2024